SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-209562
Filing Date
2021-07-07
Accepted
2021-07-07 10:46:21
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 d191716d424b3.htm 424B3 2643001
2 GRAPHIC g191716g04y89.jpg GRAPHIC 22450
3 GRAPHIC g191716g10i22.jpg GRAPHIC 82237
4 GRAPHIC g191716g10j39.jpg GRAPHIC 87895
5 GRAPHIC g191716g10r50.jpg GRAPHIC 95349
  Complete submission text file 0001193125-21-209562.txt   3041702
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257188 | Film No.: 211076570
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 212-883-0200
Royalty Pharma Holdings Ltd. (Filer) CIK: 0001868134 (see all company filings)

IRS No.: 981526515 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-257188-01 | Film No.: 211076571